These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1226403)

  • 1. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
    Singer G; Armstrong S; Evans B; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial injection of drugs: comparison of diffusion of 6-OHDA and guanethidine.
    Evans BK; Armstrong S; Singer G; Cook RD; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(2):205-28. PubMed ID: 1096173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic intracranial injection of low and high concentrations of guanethidine in the rat.
    Evans BK; Singer G; Armstrong S; Saunders PE; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(2):219-28. PubMed ID: 1096174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial injections of 6-OHDA. Comparison of catecholamine-depleting effects of different volumes and concentrations.
    Willis GL; Singer G; Evans BK
    Pharmacol Biochem Behav; 1976 Aug; 5(2):207-13. PubMed ID: 996052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor activity and alimentary behavior after radio-frequency and 6-OHDA lesions of lateral hypothalamus and substantia nigra in cats.
    Konopacki J
    Acta Neurobiol Exp (Wars); 1984; 44(1):17-28. PubMed ID: 6426254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intrahypothalamic injections of guanethidine on catecholamine fluorescence, food intake and temperature regulation in the rat.
    Armstrong S; Burnstock G; Evans B; Singer G
    Pharmacol Biochem Behav; 1973; 1(3):307-12. PubMed ID: 4590739
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol drinking in the rat after destruction of serotonergic and catecholaminergic neurons in the brain.
    Myers RD; Melchior CL
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):363-78. PubMed ID: 1162179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of peripherally administered 6-hydroxydopamine on food and water intake in rats.
    Gardiner SM; Bennett T
    Med Biol; 1978 Jun; 56(3):156-60. PubMed ID: 682699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological basis for the lateral hypothalamic syndrome.
    Singer G; Willis GL
    Brain Res Bull; 1977; 2(6):485-9. PubMed ID: 272222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine anorexia: the effect of radio-frequency lesions and 6-OHDA injections into dopaminergic nigro-striatal bundle in cats.
    Konopacki J
    Pol J Pharmacol Pharm; 1983; 35(6):497-502. PubMed ID: 6429650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of action of the abortive effect of 6-hydroxydopamine in rats.
    MacDonald E; Airaksinen MM
    Med Biol; 1981 Apr; 59(2):111-5. PubMed ID: 7311627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
    Zigmond MJ; Stricker EM
    Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin acts through catecholaminergic mechanisms in the hypothalamus to influence ingestive behaviour in the rat.
    Tsai SH; Passaro E; Lin MT
    Neuropharmacology; 1984 Nov; 23(11):1351-6. PubMed ID: 6441894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat.
    Pappas BA; Peters DA; Sobrian AK; Blouin A; Drew B
    Pharmacol Biochem Behav; 1975; 3(4):681-5. PubMed ID: 242015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in the effects of 6-hydroxydopamine on rat learning with intraventricular and local administration into nuclei of the brain catecholaminergic system].
    Gromova EA; Semenova TP; Grishchenko NI
    Biull Eksp Biol Med; 1983 Aug; 96(8):6-8. PubMed ID: 6411146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central adrenergic neurons in DOCA-salt hypertension.
    Lamprecht F; Jacobowitz DM; Richardson JS; Kopin IJ
    J Neurosci Res; 1975; 1(3-4):227-34. PubMed ID: 1225988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
    Iczkiewicz J; Rose S; Jenner P
    Exp Neurol; 2007 Sep; 207(1):95-106. PubMed ID: 17643430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intracranial injections of 6-OHDA on food and water intakes, body temperature and body weight regulation in the rat.
    Singer G; Armstrong S
    Pharmacol Biochem Behav; 1976 Sep; 5(3):309-17. PubMed ID: 996064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C; Okamura H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.